Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVA237 in patients with COPD
NCT01005901Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2009
- Primary completion
- Dec 2010
- Countries
- 11
01
Overview
A Phase 3 trial of glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Oct 2009; status: completed.
02
Drugs
glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01005901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005901.